TITLE

SWOT Analysis

PUB. DATE
June 2007
SOURCE
Angiotech Pharmaceuticals, Inc. SWOT Analysis;Jun2007, p5
SOURCE TYPE
SWOT Analysis
DOC. TYPE
SWOT Analysis
ABSTRACT
A business analysis of Angiotech Pharmaceuticals Inc., which is a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include market leadership. Weaknesses include lack of adequate manufacturing facilities. Opportunities for improvement includ product approvals. Threats to the company include increasing competition.
ACCESSION #
25628450

 

Related Articles

  • Angiotech Pharmaceuticals, Inc. SWOT Analysis.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;Jun2007, p1 

    A company profile of Angiotech Pharmaceuticals Inc., which is a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, is presented. An overview of the company is given, along with key facts including contact information, number of employees...

  • Key Facts.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;Jun2007, p4 

    Key facts about Angiotech Pharmaceuticals Inc., which is a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and number...

  • Company Overview.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;Jun2007, p4 

    An overview of Angiotech Pharmaceuticals Inc., which is a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, is presented. Data is included on revenues generated in fiscal year ended December 2006, as well as principal business offered,...

  • Angiotech Pharmaceuticals, Inc. SWOT Analysis.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;2006, p1 

    A company profile of Angiotech Pharmaceuticals Inc., a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, is presented. An overview of the company is given, along with key facts including contact information, number of employees and...

  • Key Facts.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;May2007, p4 

    Key facts about Angiotech Pharmaceuticals Inc. (Angiotech), a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and...

  • DATAMONITOR: Angiotech Pharmaceuticals, Inc.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;Nov2010, p1 

    A company profile of Angiotech Pharmaceuticals Inc., which is a specialty pharmaceutical and medical device company, is presented. An overview of the company is given, along with key facts including contact information, number of employees and revenues. A SWOT analysis is provided which includes...

  • Key Facts.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;2006, p4 

    Key facts about Angiotech Pharmaceuticals Inc., a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, are presented. Address and contact information is given, as well as statistics on revenues, financial year end data and number of...

  • Angiotech Pharmaceuticals, Inc. SWOT Analysis.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;May2007, p1 

    A company profile of Angiotech Pharmaceuticals Inc. (Angiotech), a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, is presented. An overview of the company is given, along with key facts including contact information, number of...

  • Company Overview.  // Angiotech Pharmaceuticals, Inc. SWOT Analysis;May2007, p4 

    An overview of Angiotech Pharmaceuticals Inc. (Angiotech), a specialty pharmaceutical company developing and commercializing drug-coated medical devices and biomaterials, is presented. Data is included on revenues generated in fiscal year ended December 2006, as well as principal business...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics